Antibodies for the 21st Century
Hotel Del Coronado
1500 Orange Ave
Coronado, California

Schedule of Presentations:

Wednesday, January 12, 2011
07:00:00 Conference Registration
07:30:00 Breakfast Presentation
08:10:00 Selection & Design
08:15:00 Chairperson’s Opening Remarks
08:20:00 Opening Keynote Presentation | Adimab’s Novel Human Antibody Discovery Platform Tillman U. Gerngross
09:00:00 Expanding Chemical Diversity of Antibodies: Unnatural Amino Acids for Novel Antibody Functions Vaughn Smider
09:30:00 Phage Display Generation of Human Anti-Transferrin Receptor Cytotoxic Monovalent Antibody Fragments Marie-Alix Poul
10:00:00 Coffee Break, Exhibit and Poster Viewing
10:45:00 Design and Application of Antibody Cysteine Variants Bernhard Helk
11:15:00 Impact of Post-Translational Modifications on Antibody Effector Functions Shantha Raju
11:45:00 Using Dip and Read Label-Free Assays for Rapid Antibody-Antigen Characterization Brian R. Miller
12:15:00 Close of Morning Session
12:30:00 Luncheon Presentations | or Lunch on Your Own
13:55:00 Enhancing Properties Through Powers of Prediction
14:00:00 Chairperson’s Remarks
14:05:00 Energy-Based Analysis and Prediction of the Orientation between Light- and Heavy-Chain Antibody Variable Domains Matt Jacobson
14:35:00 Engineering Biotherapeutics for Reduced Immunogenicity Gordon Webster
15:05:00 Engineered Antibodies and Molecular Imaging: Shedding Light on Drug Development Anna M Wu
15:35:00 Sponsored Presentation (Opportunity Available)
15:50:00 Networking Refreshment Break
16:25:00 Antibody Epitopes
16:30:00 Structure-Based Prediction of Antibody Epitopes Julia Ponomarenko
17:00:00 Mapping of Discontinuous Conformational Epitope by the Combination of Amide Hydrogen/Deuterium Exchange Mass Spectrometry and Docking Yoshitomo Hamuro
17:30:00 Reception in the Exhibit Hall
18:30:00 Close of Day
Thursday, January 13, 2011
07:30:00 Breakfast Presentation |or Morning Coffee
08:05:00 Engineering to Fight Disease
08:15:00 Chairperson’s Opening Remarks
08:20:00 Mono- and Multispecific Candidate Therapeutics Based on Engineered Antibody Domains Dimiter Dimitrov
08:50:00 Antibody Fusion Proteins for the Treatment of Malignancy Sherie Morrison
09:20:00 Immunoconjugates for Oncology: Fewer Barriers to Delivering Cytotoxicity Now? Alejandro D. Ricart
09:50:00 Best Practices used in the Design of Computer Based Models for Antibodies Francisco G. Hernandez-Guzman
10:05:00 Coffee Break, | Exhibit and Poster Viewing
10:30:00 Poster Awards in the Exhibit Hall
10:45:00 Endogenous Anti-IFNa Autoantibodies in Patients with Systemic Lupus Erythematosus are Associated with Decreased IFN-Pathway and Disease Activity Alyssa Morimoto
11:15:00 Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity Christian Heinis
11:45:00 Extending Half-Life Through Targeted PEGylation Antony Godwin
12:15:00 Close of Morning Session
12:30:00 The Role of Technology and Partnerships in the Development of a First-in-Class Antibody Using the Virtual R&D Model Alem Truneh
13:00:00 Luncheon Presentation | or Lunch on Your Own
13:30:00 End of Conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.